Esmo Congress 2024

Esmo Congress 2024. The esmo congress 2024 offers companies that are active in the field of medical oncology and related therapies and technologies the opportunity to play a part in an established,. All congress resources have now been published:

Prelude plans to conclude dose escalation by the end of 2024 and determine an optimal dose for subsequent phase 2 trials. This annual meeting is designed for researchers and clinicians.